HCA Healthcare Q2 Earnings Surpass Estimates Despite Stock Dip
HCA Healthcare Inc. delivered a robust second-quarter performance, with adjusted EPS of $6.84 beating estimates by 10.5%. Revenue climbed 6.4% year-over-year to $18.605 billion, while adjusted EBITDA ROSE 8.4% to $3.849 billion. The hospital giant repurchased 7 million shares and raised its quarterly dividend to $0.72, signaling confidence in its financial health.
Despite these strong results, HCA shares fell 2.83% to $331.83 midday Friday. The decline appears disconnected from fundamentals, as operational cash flows nearly doubled to $4.210 billion. Management raised full-year guidance, underscoring momentum in the healthcare sector.